ELIMINATION OF FALSE RESULTS OF MEDICINES MICROBIOLOGICAL TESTING

The validity of medicines microbial quality testing relies on the adequacy of the test procedure employed. The aim of the study was to analyse factors triggering false results during microbial quality testing of non-sterile  medicinal products, as well as to find ways of their elimination.  Materials and methods: the study was focused on non-sterile  medicinal products tested for microbial quality: N-methylglucamine, L-Malic  acid, Xeroform, Fingolimod hydrochloride, Succinic  acid, Streptocide,  Aripiprazole, Doxazosin, Clopidogrel,  Moxonidine, Tilorone,  Mycophenolic acid, Folic acid, Gabapentin, Dutasteride, Imatinib,  Temozolomide. The study involved the use of the following test strains: Bacillus subtilis, Bacillus cereus, Candida albicans, Escherichia coli, Aspergillus brasiliensis, as well as of reagents and growth media. The methods  used were determination of antimicrobial  activity under conditions of microbial quality testing, and modified in-depth  testing of microbial quality of medicinal products according to the requirements of the State Pharmacopoeia of the Russian Federation, 13th edition. Results: the analysis of literature sources helped reveal the main factors causing false results of microbiological  testing and determine  ways of their elimination.  The article sets forth the results of experimental comparison of two ways of sample preparation  for solid formulations: the standard one described in the State Pharmacopoeia of the Russian Federation, 13th edition, and the one involving the use of a laboratory shaker. The article provides experimental data on specific aspects of elimination of antimicrobial activity against B. subtilis and B. cereus and the use of specific inactivators for particular medicinal products. Conclusions: a set of measures aimed at prevention of false-positive and false-negative testing results should include: sterility control of the growth media and reagents used, monitoring  of facilities; control of growth promotion  properties and selectivity of the growth media; selection of adequate incubation  conditions  and inoculation procedure with due regard to the dosage form; justification of the amount of sample, diluents and dilution factor used; consideration  of the antimicrobial activity of a medicinal product.

1. Gunar OB, Sakhno NG, Novik ES, Bulgakova GM, Kolosova LV, Buylova IA, et al. Development of microbiological methods of drug analysis. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya = Тhе Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2016;(1):15–8 (In Russ.)

2. Gunar OB. Microflora of medicines and various aspects of its study (review). Khimiko-farmatsevticheskiy zhurnal = Pharm Chem J. 2011;(2):31–40 (In Russ.). https://doi.org/10.30906/0023-1134-2011-45-2-31-40

3. Gunar OV. The risk for obtaining false microbiological results in the quality control of drugs. Farmatsiya = Pharmacy. 2005;(2):29–31 (In Russ.)

4. Gunar OV, Sakhno NG, Abramovich RA. Basics of validation of microbiological methods of pharmaceutical analysis. Moscow: PFUR; 2017 (In Russ.)

5. Gunar OV, Sakhno NG, Roshchina MV. Microbiological monitoring of the premises of the microbiology laboratory. Risk analysis. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya = Тhе Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2013;(4):12–7 (In Russ.)

6. General monograph 1.2.4.0002.15 Microbiological purity. The State pharmacopoeia of the Russian Federation. 13th ed. V. 1. Moscow; 2015 (In Russ.)

7. Gunar OV, Sakhno NG, Bulgakova GM, Buylova IA. Specific characteristics of isolation of some bacterial species from medications. Farmatsiya = Pharmacy. 2015;(3):47–52 (In Russ.)

8. Niemelä S. Uncertainty of Quantitative Determinations Derived by Cultivation of Microorganisms. Helsinki: Centre for Metrology and Accreditation; 2002.

9. European Pharmacopoeia. 9th ed. Strasbourg; 2017. Available from: http://online.edqm.eu

10. Gunar OV, Kagramanova KA. Methods for determining the antimicrobial activity of drugs. Khimiko-farmatsevticheskiy zhurnal = Pharm Chem J. 2005;(5):53–6 (In Russ.). https://doi.org/10.30906/0023-1134-2005-39-5-53-56

11. Wunschel D, Fox KF, Black GE, Fox A. Discrimination among the B. cereus group, in comparison to B. subtilis, by structural carbohydrate profiles and ribosomal RNA spacer region PCR. Syst Appl Microbiol. 1995;17(4):625–35. https://doi.org/10.1016/S0723-2020(11)80085-8

12. Buylova IA. Development of a methodical approach to the determination of microbiological purity of non-sterile drugs: Cand. Pharm. Sci. [dissertation]. Moscow; 2016 (In Russ.)

13. Galynkin VA, Zaikina NA, Kocherovets VI, Kurbanova IZ. Culture media. Handbook. St. Petersburg: Prospekt nauki; 2006 (In Russ.)